Home › Funds › Ikarian Capital, LLC › ANIP

Ikarian Capital, LLC position in ANIP

ANI PHARMACEUTICALS INC · Health Care

Ikarian Capital, LLC reported holding 272,085 shares of ANIP (ANI PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$22.5M, representing 3.62% of its reported portfolio and ranking #6 among its reported holdings. Ikarian Capital, LLC has disclosed ANIP holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)272.08K sh
Reported value held$22.52M
Portfolio Weight3.62%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's ANIP position evolved

Ikarian Capital, LLC first disclosed a stake in ANIP in Q4 2025 at 82,800 shares (US$6.5M). The position peaked in Q2 2026 at 272,085 shares, worth US$22.5M. Across 3 filings, Ikarian Capital, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 272,085 shares valued at US$22.5M — an increase of 125,000 shares quarter over quarter.. Notable position changes include a 78% increase in Q1 2026 (shares rose 8% over the following quarter), a 85% increase in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 82.80K $6.54M New
Q1 2026 147.09K $11.31M Add
Q2 2026 272.08K $22.52M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANIP and 13F data

ANIP (ANI PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Global Alpha Capital Management Ltd. (US$46.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANIP

All ANIP fund holders →

FAQ

How long has Ikarian Capital, LLC held ANIP?

Ikarian Capital, LLC has disclosed ANIP holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Ikarian Capital, LLC's current position in ANIP?

As of Q2 2026, Ikarian Capital, LLC holds 272.08K shares of ANIP (ANI PHARMACEUTICALS INC), valued at $22.52M, representing 3.62% of its reported portfolio and ranking #6.

Has Ikarian Capital, LLC been buying or selling ANIP?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC increased its position in ANIP. The position peaked in Q2 2026 at 272.08K shares.

Which other funds hold ANIP?

Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Global Alpha Capital Management Ltd., among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.